Get the latest tech news

Neuralink says the FDA designated its Blindsight implant as a 'breakthrough device'

Neuralink says the FDA has designated its experimental Blindsight implant as a 'breakthrough device.' This could help to accelerate development of the tech, which aims to restore blind people's sight, and bring it to market sooner.

Blindsight is separate from Telepathy, its implant that enables patients with spinal cord injuries to control computers using their thoughts, allowing them to play video games and design 3D objects. Neuralink owner and founder Elon Musk said in August that the company had implanted the chip into a second human patient He added that while the resolution of Blindsight is low to begin with, "eventually it has the potential [to] be better than natural vision and enable you to see in infrared, ultraviolet or even radar wavelengths."

Get the Android app